Resverlogix Corp.


Meeting of Like Minds

In 2000, Donald McCaffrey was President of BioFuture, a national conference that brought academia and industry together featuring prominent researchers from universities across North America and representatives from the biotechnology industry. Dr. Norman Wong, a clinician who had been researching atherosclerosis and ApoA-I, met Don while presenting at BioFuture 2000. During the conference they discussed the paradigm shift in the treatment of atherosclerosis from the reduction of LDL cholesterol to raising HDL cholesterol. With the common goal to develop better therapies for the treatment of cardiovascular diseases, Don and Norm founded Resverlogix. Their combined talent, along with the addition of instrumental new employees in science and business, formed the foundation that has made Resverlogix the success it is today.